Zynerba Pharmaceuticals, Inc. (ZYNE) Stock Overview
Explore Zynerba Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Zynerba Pharmaceuticals, Inc. (ZYNE)
Key Financials
Key Financials
Market Cap
70.1M
P/E Ratio
-1.59
EPS (TTM)
$-0.79
ROE
-0.59%
ZYNE Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Zynerba Pharmaceuticals, Inc. (ZYNE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.59 and a market capitalization of 70.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.